GSK Biologicals Interested in Buying BE's Vaccine Unit

A division of global drug giant Glaxo, GlaxoSmithKline Biologicals based in Belgium is in talks with the Hyderabad-based Biological E Ltd (BE) to purchase its vaccines division.

This vaccine division produces and markets a range of pediatric and adult vaccines. The Diphtheria and Tetanus vaccine has given the company a sizeable market share in the Indian vaccine market. BE claims to be the first private sector company to enter the vaccines market.

Tetanus - Causes Symptoms Diagnosis Treatment FAQs
Tetanus (or Lockjaw) is a serious preventable infection that can affect the muscles and nerves and results from contamination of wound. The vaccine against Tetanus can prevent the infection.

Recently Glaxo's current plant in Nasik faced some constraints in supplying vaccines and therefore it would be interested in buying companies with modern manufacturing facilities approved by international agencies like US FDA. The BE vaccine unit buyout will give GSK Biologicals additional capacity in India.

Source-Medindia

Poliomyelitis - About
Polio is an infectious disease caused by the poliovirus. It results in paralysis and generally affects people of all age groups, children being more susceptible

Hib Vaccine - Types, Dosage Schedule, Contraindications and Side Effects
The Hib vaccine protects children against infections like meningitis and pneumonia that are caused by the Haemophilus influenzae type b bacterium.

Safe and Effective Vaccine Against Yellow Fever
Scientists wanted to study the efficacy of inactivated cell culture vaccine against yellow fever.